EF
USNA icon

Empirical Finance’s Usana Health Sciences USNA Stock Holding History

Empirical Finance’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,469
Closed -$765K – 436
2021
Q2 		$765K Sell
7,469
-6,277
-46% -$630K 0.12% 193
2021
Q1 		$1.06M Hold
13,746
– – 0.19% 129
2020
Q4 		$1.06M Hold
13,746
– – 0.19% 129
2020
Q3 		$1.01M Buy
+13,746
New +$1.1M 0.22% 122
2017
Q1 		– Sell
-154
Closed -$10K – 550
2016
Q4 		$10K Buy
+154
New +$10K 0.01% 387

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Empirical Finance's USNA Position: Q3 2021 in Review

Empirical Finance sold out of Usana Health Sciences (USNA) in Q3 2021, closing a stake of 7,469 shares — an estimated $765K sold.

Empirical Finance first reported a position in USNA in Q4 2016 and held it in 5 quarters. The position peaked at $1.06M in Q1 2021. 180 funds tracked by Wall St. Rank hold USNA as of Q3 2021.

  • Empirical Finance reported no remaining Usana Health Sciences position as of Q3 2021 after selling out during the quarter.
  • Empirical Finance sold 7,469 Usana Health Sciences shares in Q3 2021, an estimated $765K.
  • Empirical Finance first reported a position in Usana Health Sciences in Q4 2016 and held it in 5 quarters.
  • Empirical Finance's Usana Health Sciences position peaked at $1.06M in Q1 2021.
  • 180 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2021.

Based on Empirical Finance's 13F filing for Q3 2021, filed 12 Nov 2021.